| Title | Author(s) | Issue date | ???itemlist.??? |
| Cholera-Toxin Promotes the Proliferation of Anti-Mu Antibody-Prestimulated Human B-Cells | Anastassiou, E. D.; Yamada, H.; Boumpas, D. T.; Tsokos, G. C.; Thyphronitis, G.; Balow, J. E.; Mond, J. J. | 24-Nov-2015 | - |
| Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease | Ioannou, M.; Alissafi, T.; Lazaridis, I.; Deraos, G.; Matsoukas, J.; Gravanis, A.; Mastorodemos, V.; Plaitakis, A.; Sharpe, A.; Boumpas, D. T.; Verginis, P. | 24-Nov-2015 | - |
| EULAR points to consider for conducting clinical trials in systemic lupus erythematosus | Gordon, C.; Bertsias, G.; Ioannidis, J. P.; Boletis, J.; Bombardieri, S.; Cervera, R.; Dostal, C.; Font, J.; Gilboe, I. M.; Houssiau, F.; Huizinga, T. W.; Isenberg, D.; Kallenberg, C. G.; Khamashta, M. A.; Piette, J. C.; Schneider, M.; Smolen, J. S.; Sturfelt, G.; Tincani, A.; Van Vollenhoven, R.; Boumpas, D. T. | 24-Nov-2015 | - |
| EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints | Bertsias, G. K.; Ioannidis, J. P.; Boletis, J.; Bombardieri, S.; Cervera, R.; Dostal, C.; Font, J.; Gilboe, I. M.; Houssiau, F.; Huizinga, T.; Isenberg, D.; Kallenberg, C. G.; Khamashta, M.; Piette, J. C.; Schneider, M.; Smolen, J.; Sturfelt, G.; Tincani, A.; van Vollenhoven, R.; Boumpas, D. T.; Gordon, C. | 24-Nov-2015 | - |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs | Bertsias, G. K.; Ioannidis, J. P.; Aringer, M.; Bollen, E.; Bombardieri, S.; Bruce, I. N.; Cervera, R.; Dalakas, M.; Doria, A.; Hanly, J. G.; Huizinga, T. W.; Isenberg, D.; Kallenberg, C.; Piette, J. C.; Schneider, M.; Scolding, N.; Smolen, J.; Stara, A.; Tassiulas, I.; Tektonidou, M.; Tincani, A.; van Buchem, M. A.; van Vollenhoven, R.; Ward, M.; Gordon, C.; Boumpas, D. T. | 24-Nov-2015 | - |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics | Bertsias, G.; Ioannidis, J. P.; Boletis, J.; Bombardieri, S.; Cervera, R.; Dostal, C.; Font, J.; Gilboe, I. M.; Houssiau, F.; Huizinga, T.; Isenberg, D.; Kallenberg, C. G.; Khamashta, M.; Piette, J. C.; Schneider, M.; Smolen, J.; Sturfelt, G.; Tincani, A.; van Vollenhoven, R.; Gordon, C.; Boumpas, D. T. | 24-Nov-2015 | - |
| Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology | Raptopoulou, A.; Sidiropoulos, P.; Siakka, P.; Boki, K. A.; Drosos, A. A.; Aslanidis, S.; Karras, D.; Pikazis, D.; Vassilopoulos, D.; Karassa, F.; Boumpas, D. T. | 24-Nov-2015 | - |
| Gene-Transcription during Invitro Activation of Human Lymphocytes-B with Staphylococcus-Aureus Cowan-I Strain | Boumpas, D. T.; Anastassiou, E. D.; Tsokos, G. C.; Thyphronitis, G.; Balow, J. E. | 24-Nov-2015 | - |
| Signal requirements for interleukin 4 promoter activation in human T cells | Paliogianni, F.; Hama, N.; Mavrothalassitis, G. J.; Thyphronitis, G.; Boumpas, D. T. | 24-Nov-2015 | - |
| Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece | Karageorgaki, Z. T.; Bertsias, G. K.; Mavragani, C. P.; Kritikos, H. D.; Spyropoulou-Vlachou, M.; Drosos, A. A.; Boumpas, D. T.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
